MedTrace Logo

Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer

NCT04878952 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2026-05-08

No results posted yet for this study

Summary

This trial will examine if the monitoring of daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable clinicians to deliver improved supportive care and reduce the rate of adverse events during the course of radiation treatment.

Conditions

Interventions

OTHER

Garmin Vivofit Activity Tracker

Activity tracker that is worn on the wrist.

Sponsors & Collaborators

  • Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program (PA CURE)

    collaborator UNKNOWN

  • NRG Oncology

    lead OTHER

Principal Investigators

  • Nitin Ohri, MD · NRG Oncology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-26
Primary Completion
2024-08-12
Completion
2024-08-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04878952 on ClinicalTrials.gov